In March 2023, the US government announced an ambitious new course for its national bio strategy. It’s aptly named “Bold Goals for U.S. Biotechnology and Biomanufacturing” with key targets on: Insider Dr. Min Zhou is the CEO of CM Venture Capital, a China-based investment company which partners multinationals to help them invest in next-gen technologies…
阅读更多（Read More）
